Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals

Abroad (travel likely)RecruitingPHASE3

Conditions

HIV-1-infection · Non-Adherence, Medication

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Chang Gung Memorial Hospital, Keelung, Keelung, Taiwan
Contact: Study coordinator (Nan-Yu Chen) · nanyuchen@cgmh.org.tw
Chang Gung Memorial Hospital, Taipei, Taipei, Taiwan
Contact: Study coordinator (Nan-Yu Chen) · nanyuchen@cgmh.org.tw
Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan
Contact: Study coordinator (Chien-Yu Cheng, MD, PhD) · s841060@gm.ym.edu.tw
Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Contact: Study coordinator (Nan-Yu Chen) · nanyuchen@cgmh.org.tw · +886 3 3281200

Study leads

Nan-Yu Chen, MD, PhD
Principal Investigator
Chang Gung Memorial Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection

HIV-1-infection

Abroad (travel likely)RecruitingPHASE3

Nova Iguaçu, Brazil · Rio de Janeiro, Brazil

Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance

HIV-1-infection

Abroad (travel likely)RecruitingPHASE3

Kisumu, Kenya · Mombasa, Kenya

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants

HIV

Abroad (travel likely)Recruiting

Bethesda, United States

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption

HIV

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States